Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | LCK | P06239 | 1/20 | 0.41 |
| ▸ | PPARD | Q03181 | 1/20 | 0.41 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.41 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19136513 | 0.87 | GPR84 (0.41) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL9422726 | 0.82 | GPR84 (0.44) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL25445297 | 0.80 | CA2 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL11013967 | 0.80 | CA2 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL25445437 | 0.80 | CA2 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL21730422 | 0.80 | CA2 (0.52) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL9744585 | 0.80 | GPR84 (0.61) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6116835 | 0.78 | CA1 (0.53) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6116992 | 0.78 | CA1 (0.53) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL21730445 | 0.78 | CA2 (0.55) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180333697-A1 | NOVEL ORGANIC MATERIAL FOR EXTRACTING THE URANIUM FROM AN AQUEOUS SOLUTION OF PHOSPHORIC ACID, ASSOCIATED METHODS FOR EXTRACTING AND RETRIEVING THE URANIUM AND A PRECURSOR OF SUCH AN ORGANIC MATERIAL | Orano Mining (FR) | 2018-11-22 | — | — | US | disclosed |
| US-10130932-B2 | Organic-inorganic hybrid material of use for extracting uranium (VI) from aqueous media containing phosphoric acid, processes for preparing same and uses thereof | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES (FR) | 2018-11-20 | — | — | US | disclosed |
| US-10006103-B2 | Use of an organic-inorganic hybrid material for extracting uranium(VI) from a sulfuric acid aqueous solution, issued notably from the sulfuric leaching of a uranium-bearing ore | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2018-06-26 | — | — | US | disclosed |
| US-20160289796-A1 | USE OF AN ORGANIC-INORGANIC HYBRID MATERIAL FOR EXTRACTING URANIUM(VI) FROM A SULFURIC ACID AQUEOUS SOLUTION, ISSUED NOTABLY FROM THE SULFURIC LEACHING OF A URANIUM-BEARING ORE | COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) | 2016-10-06 | — | — | US | disclosed |
| US-9441285-B2 | Bifunctional compounds useful as ligands of uranium (VI), methods of synthesising same and uses thereof | AREVA MINES (FR) | 2016-09-13 | — | — | US | disclosed |
| US-20160016150-A1 | ORGANIC-INORGANIC HYBRID MATERIAL OF USE FOR EXTRACTING URANIUM (VI) FROM AQUEOUS MEDIA CONTAINING PHOSPHORIC ACID, PROCESSES FOR PREPARING SAME AND USES THEREOF | UNIVERSITÉ DE MONTPELLIER (FR) | 2016-01-21 | — | — | US | disclosed |
| US-20150133688-A1 | BIFUNCTIONAL COMPOUNDS USEFUL AS LIGANDS OF URANIUM (VI), METHODS OF SYNTHESISING SAME AND USES THEREOF | AREVA MINES (FR) | 2015-05-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150133688-A1 | BIFUNCTIONAL COMPOUNDS USEFUL AS LIGANDS OF URANIUM (VI), METHODS OF SYNTHESISING SAME AND USES THEREOF | URB2, CHRM2, C1S | GPR84 1153/4885FFAR1 703/4885MAPT 2475/4885 |
| US-20180333697-A1 | NOVEL ORGANIC MATERIAL FOR EXTRACTING THE URANIUM FROM AN AQUEOUS SOLUTION OF PHOSPHORIC ACID, ASSOCIATED METHODS FOR EXTRACTING AND RETRIEVING THE URANIUM AND A PRECURSOR OF SUCH AN ORGANIC MATERIAL | UGP2, PGM2, UMPS | GPR84 2700/4885FFAR1 3406/4885MAPT 810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.